Fulgent Genetics to Announce First Quarter 2021 Financial Results on Thursday May 6, 2021
April 16, 2021 08:00 ET
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., April 16, 2021 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions...
Fulgent Genetics Awarded Contract from CDC to Study Variants of COVID-19 Virus
March 15, 2021 16:05 ET
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., March 15, 2021 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “Company”), a technology company providing comprehensive testing solutions...
Fulgent Genetics to Participate in the Oppenheimer 31st Annual Healthcare Conference
March 05, 2021 08:00 ET
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., March 05, 2021 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions...
Fulgent Genetics Reports Record Fourth Quarter and Full Year 2020 Financial Results
March 04, 2021 16:05 ET
|
Fulgent Genetics, Inc.
Fourth Quarter 2020 Results: Record Revenue of $295.0 million, growing more than 3,400% year-over-yearRecord Billable tests delivered approximately 3.2 million, approximately 230 times the volume of...
Fulgent Genetics to Announce Fourth Quarter and Full Year 2020 Financial Results on Thursday March 4, 2021
February 18, 2021 08:00 ET
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions...
Fulgent Genetics to Participate in the H.C. Wainwright BIOCONNECT 2021 Conference
January 06, 2021 08:00 ET
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions...
Fulgent Genetics Extends Partnership with New York City Test and Trace for COVID-19 Testing, Awarded Contract for 2021 School Year
December 29, 2020 08:00 ET
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., Dec. 29, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics (Nasdaq: FLGT), a technology company providing comprehensive testing solutions through its scalable technology platform, today...
Fulgent Genetics to Participate in the Piper Sandler 32nd Annual Healthcare Conference
November 24, 2020 08:00 ET
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., Nov. 24, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions...
Fulgent Genetics Announces Increase to Full Year 2020 Guidance to $300 million
November 23, 2020 08:00 ET
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions...
Fulgent Genetics to Participate in the Credit Suisse 29th Annual Virtual Healthcare Conference
November 10, 2020 16:05 ET
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions...